Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Related VRX
10 Most Volatile Stocks Investors Should Know For Q3 Earnings
Benzinga's Option Alert Recap From October 13
The Vetr community has upgraded $VRX to 3.5-Stars. (Vetr)
Related GLW
Jim Cramer Shares His Thoughts On Corning, Procter & Gamble And More
5 Biggest Price Target Changes For Tuesday

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: Mad MoneyCNBC Jim Cramer Media


Related Articles (GLW + SGYP)

View Comments and Join the Discussion!

Partner Center